Tracks
| Tracks and sub-tracks |
|---|
|
TRACK A: BASIC AND TRANSLATIONAL RESEARCH
A1 : Immunology – research into diagnostics and immunity A2 : Drug and vaccine development A3 : Diagnostics, including drug-resistance determination – technical aspects and new developments A4 : Imaging and image analysis for diagnostics (including AI) |
|
TRACK B: LUNG HEALTH (pneumonia, asthma, COPD, other respiratory diseases in adults and children) |
|
TRACK C: Non-Tuberculous Mycobacteria |
|
TRACK D: OCCUPATIONAL HEALTH |
|
TRACK E: POLLUTION AND CLIMATE CHANGE |
|
TRACK F: ZOONOTIC DISEASE |
|
TRACK G: CLINICAL TRIALS
G1 : Ethics G2 : Design and analysis G3 : Early phase (I/) G4 : Late phase (II/III) G5 : Pharmacokinetics and pharmacodynamics G6 : Health economics |
|
TRACK H: HEALTH SYSTEMS STRENGTHENING
H1 : Training, education and programmatic capacity building H2 : Information systems and surveillance H3 : Universal health coverage (UHC) H4 : Digital health technologies |
|
TRACK I: POLICY, CIVIL SOCIETY AND HUMAN RIGHTS
I1 : Civil society, advocacy and community engagement I2 : Key affected populations: behavioural, social, and cultural issues and contexts I3 : Human rights and ethics I4 : Communication/social media I5 : UNHLM: catalyzing to End TB I6 : Evidence-based community programming I7 : Systems for private, corporate, and public sector engagement |
|
TRACK J: TOBACCO CONTROL
J1 : Tobacco and comorbidities: including NCDs, TB and HIV J2 : Tobacco industry interference J3 : Tobacco control strategies J4 : E-cigarettes and non-combustible tobacco products |
| TB specific tracks |
|---|
|
TRACK K: TUBERCULOSIS – CLINICAL AND OPERATIONAL RESEARCH
K1 : TB laboratory service implementation and operations K2 : TB diagnostics K3 : TB screening K4 : Identification and management of Mtb infection K5 : Mtb transmission dynamics and bioaerosols K6 : TB treatment K7 : TB and comorbidities (HIV, diabetes, malnutrition, mental health, etc.) K8 : Health and well-being post TB |
|
TRACK L: TUBERCULOSIS – POLICIES AND CLINICAL & PROGRAMMATIC IMPLEMENTATION
L1 : TB prevention L2 : Management of TB L3 : Maternal and child TB L4 : Health and well-being post TB L5 : Service provision (including person-centered care) L6 : Global and local policies and politics, including funding and accountability L7 : Health economics L8 : Infection prevention and control |
|
TRACK M: TUBERCULOSIS – EPIDEMIOLOGY
M1 : Mtb infection across the life course M2 : TB and comorbidities (HIV, diabetes, malnutrition, mental health, etc.) M3 : Health and well-being post TB M4 : Mathematical modelling M5 : Resistant TB |
Note that TBScience will have 4 themes that will be announced in the coming weeks (separate call for abstract submissions: 14 May – 10 June)